ABEO Earnings Abeona Therapeutics Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–38 of 38
| Q2 2026 | 2026-06-30 | -0.35 | 2026-08-13 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.30 | 2026-05-13 | 10-Q |
| Q4 2025 (derived) | 2025-12-31 | -0.36 | 2026-03-17 | 10-K |
| FY 2025 | 2025-12-31 | 1.01 | 2026-03-17 | 10-K |
| Q3 2025 | 2025-09-30 | -0.10 | 2025-11-12 | 10-Q |
| Q2 2025 | 2025-06-30 | 1.71 | 2025-08-14 | 10-Q |
| Q1 2025 | 2025-03-31 | -0.24 | 2025-05-15 | 10-Q |
| Q4 2024 (derived) | 2024-12-31 | 0.50 | 2025-03-20 | 10-K |
| FY 2024 | 2024-12-31 | -1.55 | 2025-03-20 | 10-K |
| Q3 2024 | 2024-09-30 | -0.63 | 2024-11-14 | 10-Q |
| Q2 2024 | 2024-06-30 | -0.26 | 2024-08-12 | 10-Q |
| Q1 2024 | 2024-03-31 | -1.16 | 2024-05-15 | 10-Q |
| Q4 2023 (derived) | 2023-12-31 | -0.59 | 2024-03-18 | 10-K |
| FY 2023 | 2023-12-31 | -2.53 | 2024-03-18 | 10-K |
| Q3 2023 | 2023-09-30 | -0.48 | 2023-11-13 | 10-Q |
| Q2 2023 | 2023-06-30 | -0.92 | 2023-08-08 | 10-Q |
| Q1 2023 | 2023-03-31 | -0.54 | — | — |
| FY 2022 | 2022-12-31 | -5.53 | — | — |
| Q3 2022 | 2022-09-30 | -1.00 | — | — |
| Q2 2022 | 2022-06-30 | 1.36 | — | — |
| Q4 2014 (derived) | 2014-12-31 | -10.57 | 2015-03-31 | 10-K |
| FY 2014 | 2014-12-31 | -15.26 | 2015-03-31 | 10-K |
| Q3 2014 | 2014-09-30 | -4.15 | 2014-11-14 | 10-Q |
| Q2 2014 | 2014-06-30 | -0.51 | 2014-08-14 | 10-Q |
| Q1 2014 | 2014-03-31 | -0.03 | 2014-05-12 | 10-Q |
| Q4 2013 (derived) | 2013-12-31 | 4.65 | 2014-03-26 | 10-K |
| FY 2013 | 2013-12-31 | 3.04 | 2014-03-26 | 10-K |
| Q3 2013 | 2013-09-30 | -1.77 | 2013-11-14 | 10-Q |
| Q2 2013 | 2013-06-30 | 0.03 | 2013-08-14 | 10-Q |
| Q1 2013 | 2013-03-31 | 0.13 | 2013-05-15 | 10-Q |
| Q4 2012 (derived) | 2012-12-31 | 0.79 | — | — |
| FY 2012 | 2012-12-31 | -0.52 | — | — |
| Q3 2012 | 2012-09-30 | -0.63 | — | — |
| Q2 2012 | 2012-06-30 | -0.46 | — | — |
| Q1 2012 | 2012-03-31 | -0.22 | 2012-05-15 | 10-Q |
| Q2 2011 | 2011-06-30 | -0.09 | 2011-08-15 | 10-Q |
| Q1 2011 | 2011-03-31 | -0.12 | — | — |
| Q2 2010 | 2010-06-30 | 0.07 | — | — |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.